|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-16
|
|
pubmed:abstractText |
Risk factors for breast cancer are related to endogenous hormones and reproductive events. As such, traditional cancer prevention strategies are not easily applicable. Tamoxifen and other selective estrogen receptor modulators (SERMs) offer a new preventive strategy for some high-risk women, but have not yet been shown to be efficacious for all women. New tools to identify high-risk women are needed. One such tool is the development of a multigenic model of breast cancer susceptibility that can be used to screen women in order to identify those who carry a combination of alleles that puts them at significantly increased risk.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10070957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10376571,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10383140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10463580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10519398,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10547390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-10548311,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-1964490,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-7849715,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9067272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9485002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9667690,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9672266,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9672273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9672274,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9747868,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9796640,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11250721-9796641
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aromatase,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens,
http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Selective Estrogen Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Steroid 17-alpha-Hydroxylase,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1465-5411
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
277-82
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11250721-Adult,
pubmed-meshheading:11250721-Aged,
pubmed-meshheading:11250721-Aged, 80 and over,
pubmed-meshheading:11250721-Anticarcinogenic Agents,
pubmed-meshheading:11250721-Aromatase,
pubmed-meshheading:11250721-Breast Neoplasms,
pubmed-meshheading:11250721-Case-Control Studies,
pubmed-meshheading:11250721-Estradiol Dehydrogenases,
pubmed-meshheading:11250721-Estrogen Receptor alpha,
pubmed-meshheading:11250721-Estrogens,
pubmed-meshheading:11250721-Ethnic Groups,
pubmed-meshheading:11250721-Female,
pubmed-meshheading:11250721-Forecasting,
pubmed-meshheading:11250721-Genetic Predisposition to Disease,
pubmed-meshheading:11250721-Genetic Testing,
pubmed-meshheading:11250721-Humans,
pubmed-meshheading:11250721-Middle Aged,
pubmed-meshheading:11250721-Models, Genetic,
pubmed-meshheading:11250721-Ovary,
pubmed-meshheading:11250721-Polymorphism, Genetic,
pubmed-meshheading:11250721-Raloxifene,
pubmed-meshheading:11250721-Receptors, Estrogen,
pubmed-meshheading:11250721-Reproductive History,
pubmed-meshheading:11250721-Risk Factors,
pubmed-meshheading:11250721-Selective Estrogen Receptor Modulators,
pubmed-meshheading:11250721-Steroid 17-alpha-Hydroxylase,
pubmed-meshheading:11250721-Tamoxifen
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.
|
|
pubmed:affiliation |
American Cancer Society, National Home Office, Atlanta, Georgia 30329-4251, USA.
|
|
pubmed:publicationType |
Journal Article,
Review
|
